Speaker's Profile
Riad Salem, MD, MBA, FSIR
23 Results Found, Showing 1 - 23
Sort By:
View:
Filter By:
Date/Time
Conference
Keyword
My Content
CC13a - Y-90 Radioembolization Offers No Discernible Advantages Over Traditional Chemoembolization in the Treatment of Hepatic Malignancies
Date/Time:
March 17, 2010 10:00am - 12:00pm
Length:
27m 50s -
47 Slides
CC15c - Common Statistical Tests
Date/Time:
March 17, 2010 4:00pm - 6:00pm
Length:
15m 03s -
1 Slide
HA02b - Impact of Active Interventional Oncology Practice on Your Institution - the Downstream Effects of IR
Date/Time:
March 14, 2010 4:00pm - 6:00pm
Length:
09m 17s -
1 Slide
CC04f - Future Research in HCC/Ongoing Trials
Date/Time:
March 8, 2009 5:40pm - 6:00pm
Length:
25m 38s -
1 Slide
SY01h - Initiative Success (Oncology)
Date/Time:
March 7, 2009 1:18pm - 1:30pm
Length:
10m 10s -
15 Slides
3.1 - Clinical Care: Radioembolization: Regulatory Aspects and Practice Building
Length:
09m 00s -
39 Slides
3.5 - Complications Following Radioembolization
Length:
11m 14s -
39 Slides
CC02b - Y-90 Radioembolization: Ready for Prime Time?
Date/Time:
March 16, 2008
Length:
09m 21s -
1 Slide
CC02g - Debate: The Future of Transarterial Therapy for Liver Cancer (TACE is and will Remain the Standard, Y-90 will Eclipse TACE for Many Diagnoses)
Date/Time:
March 16, 2008
Length:
06m 32s -
1 Slide
CC22d - Cases 10-12
Date/Time:
March 19, 2008
Length:
13m 17s -
1 Slide
PL07d - Imaging the HCC Patient: From Diagnosis to Treatment
Date/Time:
March 19, 2008
Length:
13m 42s -
1 Slide
SS04a - Y-90 Radioembolization in a Cohort of Advanced HCC Patients: Comparison with Systemic Therapy
Date/Time:
March 16, 2008
Length:
07m 38s -
1 Slide
02.08 - TACE: Chemoabsorbing Embolic Agents versus Radiation Beads
Date/Time:
November 12, 2007 11:10am - 1:20pm
Length:
09m 43s -
22 Slides
Format:
Synched Audio / Slides
10.6 - Radioembolization for HCC: Indications, Results and Perspectives
Date/Time:
April 26, 2007 3:30pm - 5:30pm
Length:
10m 22s -
33 Slides
SY03r - Radioembolization for Colon Cancer Metastases
Date/Time:
March 6, 2007 7:00am - 12:00pm
Length:
07m 59s -
24 Slides
PL08c - Y90 Microspheres: Do the Results Justify the Costs and Logistics?
Date/Time:
April 3, 2006 10:00am - 12:00pm
Length:
09m 50s -
18 Slides
SS03e - Yttrium-90 Treatment for Metastatic Cancer to the Liver: Midterm Results
Date/Time:
March 31, 2006 10:30am - 12:00pm
Length:
10m 32s -
26 Slides
SS03g - Treatment of Unresectable Hepatocellular Carcinoma Using Intra-Arterial Y90 (TheraSphere): Long-Term Follow-Up
Date/Time:
March 31, 2006 10:30am - 12:00pm
Length:
13m 13s -
31 Slides
SS16i - TBD
Date/Time:
April 2, 2006 8:00am - 9:30am
Length:
10m 34s -
18 Slides
SS27a - The "Perclose Run": Is It Necessary?
Date/Time:
April 3, 2006 1:30pm - 3:00pm
Length:
10m 14s -
22 Slides
SY03a - From Caring to Cure: Initiating a Practice / Uniqueness of the Oncology Patient
Date/Time:
April 4, 2006 7:30am - 1:00pm
PL08f - Yttrium 90: Concepts and Principles
Date/Time:
March 5, 2005 1:00pm - 2:00pm
Length:
17m 41s -
72 Slides
SY02e - Assessment of the HCC Patient
Date/Time:
March 5, 2005 1:00pm - 2:00pm
Length:
19m 56s -
28 Slides
